Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by OneAscent Wealth Management LLC

OneAscent Wealth Management LLC lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 17.2% during the first quarter, Holdings Channel.com reports. The fund owned 1,906 shares of the medical equipment provider’s stock after selling 397 shares during the period. OneAscent Wealth Management LLC’s holdings in Intuitive Surgical were worth $761,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Baystate Wealth Management LLC increased its holdings in shares of Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 45 shares in the last quarter. MCF Advisors LLC raised its stake in Intuitive Surgical by 108.1% during the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 40 shares during the period. Headinvest LLC purchased a new stake in shares of Intuitive Surgical in the third quarter valued at $28,000. Able Wealth Management LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $28,000. Finally, Stone House Investment Management LLC grew its holdings in shares of Intuitive Surgical by 100.0% during the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 50 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.1 %

NASDAQ ISRG traded down $0.26 on Friday, hitting $444.85. 3,106,192 shares of the company were exchanged, compared to its average volume of 1,372,778. The company has a market cap of $157.79 billion, a PE ratio of 80.30, a PEG ratio of 5.75 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $447.11. The stock has a fifty day moving average of $403.83 and a 200-day moving average of $382.69.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.10. The firm had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business’s quarterly revenue was up 11.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.00 earnings per share. On average, analysts expect that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of research analyst reports. Citigroup increased their price target on shares of Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. BTIG Research boosted their price target on shares of Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a report on Friday, April 19th. Piper Sandler lifted their price objective on Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research report on Friday, April 19th. The Goldman Sachs Group assumed coverage on Intuitive Surgical in a research report on Thursday, May 30th. They issued a “buy” rating and a $500.00 target price on the stock. Finally, Stifel Nicolaus lifted their price target on Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a report on Monday, April 8th. Five equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $403.67.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 175 shares of the stock in a transaction on Monday, May 13th. The stock was sold at an average price of $389.16, for a total transaction of $68,103.00. Following the transaction, the senior vice president now directly owns 883 shares of the company’s stock, valued at approximately $343,628.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, EVP Myriam Curet sold 5,318 shares of the company’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the transaction, the executive vice president now owns 298 shares in the company, valued at $110,456.68. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 175 shares of the business’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $389.16, for a total value of $68,103.00. Following the sale, the senior vice president now owns 883 shares in the company, valued at approximately $343,628.28. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 17,956 shares of company stock worth $6,927,011. 0.90% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.